Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Week in Review: The Latest from PhRMA

By Priscilla VanderVeer  |    July 31, 2015
Medicare: Medicare celebrated its 50th anniversary this week! To note the occasion, we looked at the continued success of Part D, which helps many older Americans and people living with disabilities:   Read More

Celebrating Anniversaries: Americans with Disabilities Act

By Guest Contributor  |    July 31, 2015
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Fact Check Friday: The Truth about IPR and Biopharmaceutical Patents

By Tina Stow  |    July 31, 2015
Today, we’re pleased to be kicking off our newest Catalyst blog series: Fact Check Friday. We’ll be using this space to separate truth from fiction and set the record straight when the rhetoric...   Read More

Happy 50th Anniversary Medicare!

By Allyson Funk  |    July 30, 2015
Today we bring you a special edition of #MedicareMonday on Medicare’s 50th anniversary. As Medicare celebrates 50 years, we wanted to remind you about some of our Medicare resources and continue...   Read More

4 Things to Know about the Medicare Part D Premium Announcement

By Allyson Funk  |    July 29, 2015
Today, the Centers for Medicare & Medicaid Services announced that average monthly premiums for Medicare Part D prescription drug coverage in 2016 will remain stable at an estimated $32.50 per month....   Read More

ICYMI: Community Oncologists Speak Out Against Hospital Cancer Doctors’ Drug Price Control Proposals

By Holly Campbell  |    July 29, 2015
In case you missed it, the Community Oncology Alliance (COA) called the drug-price control recommendations made by 118 oncologists published in the journal Mayo Clinic Proceedings “misguided because...   Read More

3 Points You Need to Know about the Federal Government’s Health Spending Projections

By Robert Zirkelbach  |    July 28, 2015
New National Health Expenditure (NHE) projections released today by the Centers for Medicare & Medicaid Services (CMS) call into question claims that have been made in recent months about the...   Read More

New Study Examines Clinical Pathways: An Overview of Current Practices and Potential Implications for Patients, Payers, and Providers

By Kelsey Lang  |    July 28, 2015
As health care payers seek to transition to new, value-based payment models, clinical pathways are one strategy payers and providers are using in their efforts to contain costs and promote...   Read More

No Two Patients with High Cholesterol are the Same: Meet George and Betty

By Holly Campbell  |    July 28, 2015
Last week, we introduced two hypothetical patients, Sheryl and Bill, who are working to get their cholesterol levels under control. Today we highlight George and Betty. George is able to control his...   Read More

Patient Groups, Members of Congress and Other State-Based Stakeholders Agree: Stop the Abuse of Biopharmaceutical Patents

By Tina Stow  |    July 28, 2015
As Congress considers patent legislation known as H.R. 9, the Innovation Act, and S. 1137, the PATENT Act, health care leaders – from patient groups to Members of Congress to trade associations –...   Read More

Medicare Monday: More Medicines in Development for Older Americans

By Allyson Funk  |    July 27, 2015
This Thursday, Medicare celebrates its 50th anniversary! One critical part of Medicare for older Americans and people living with disabilities is the Part D prescription drug benefit that began in...   Read More

Biopharmaceutical Industry Strongly Committed to Responsible Clinical Trial Data Sharing to Improve Public Health

By Jeff Francer  |    July 23, 2015
The biopharmaceutical industry remains committed to enhancing public health through responsible data sharing that recognizes the importance of protecting patient privacy, respects the integrity of...   Read More

Focusing on Only 1% of Spending Will Not Solve Nation’s Health Care Challenges

By Robert Zirkelbach  |    July 23, 2015
Commentary published today in Mayo Clinic Proceedings highlights a critical challenge facing cancer patients: the ability to access the medicines they need. But rather than address this issue...   Read More

I’m Not Average: Doreen’s Struggle with Cholesterol (Video)

By Holly Campbell  |    July 22, 2015
After a heart attack at only 39 and subsequent diagnosis of high cholesterol, Doreen was in shock. “That was the beginning of a great challenge for me,” says Doreen. She knew she had to stay alive...   Read More

No Two Patients with High Cholesterol are the Same: Meet Sheryl and Bill

By Holly Campbell  |    July 21, 2015
Even though Sheryl and Bill both have high cholesterol they have two very different stories. Sheryl is able to control her cholesterol level through statin therapy combined with lifestyle changes...   Read More

How many Americans could potentially be treated with new PCSK9 inhibitors? (Hint: It won’t be as many as critics claim)

By Holly Campbell  |    July 20, 2015
Despite claims that tens of millions of Americans could be eligible for treatment with a new class of cholesterol-lowering medications, called PCSK9 inhibitors, the fact is these new medicines will...   Read More

Medicare Monday: New Research Finds Beneficiaries Live Longer After Implementation of Medicare Part D

By Allyson Funk  |    July 20, 2015
New research published last week in the American Journal of Managed Care found reductions in mortality among Medicare beneficiaries following the implementation of Medicare Part D. We’ve talked...   Read More

Week in Review: The Latest from PhRMA

By Priscilla VanderVeer  |    July 17, 2015
Neurological Disorders: America’s biopharmaceutical companies are committed to developing innovative new treatments for the nearly 50 million Americans affected by neurological disorders. This week,...   Read More

New Chart Pack: Biopharmaceuticals in Government Programs

By Allyson Funk  |    July 16, 2015
Today, PhRMA released a new resource on biopharmaceuticals in government programs. This new chart pack features key facts about prescription medicines in four major government programs – Medicare,...   Read More

Medicine Spending Relatively Stable Following Increased Regulatory Data Protection in Canada and Japan

By Mark Grayson  |    July 16, 2015
There has been much discussion about the effects of adding 12 years of data protection for biologics in the TPP.  However, fears that this could add to the cost of healthcare seem to be unfounded. A ...   Read More

In Case You Missed It: Progress and Promise in Alzheimer’s Research

By Tina Stow  |    July 15, 2015
PhRMA recently convened a panel of health care experts for a live webcast discussion about the current state of research to treat and care for Alzheimer’s disease. Dr. Bill Chin of PhRMA moderated...   Read More

The War on Alzheimer’s: Progress and Challenges of Biopharmaceutical Research

By Bill Chin, M.D.  |    July 15, 2015
Alzheimer’s disease steals memories, relationships and independence. It is a ruthless, devastating disease ravaging more than 5 million people in the United States alone, and is the sixth-leading...   Read More

Burden on Patients: Questions on Access to Cancer Medicines in Health Exchange Plans

By Allyson Funk  |    July 14, 2015
Patients, especially those suffering from chronic conditions, deserve access to the medicines they need to live longer, healthier lives. Today, PhRMA released a new fact sheet on access to oncology...   Read More

Are new hep C treatments cost effective? Doctors say answer is “a resounding yes”

By Robert Zirkelbach  |    July 14, 2015
In case you missed it, a recent Bloomberg story features a new report from an influential panel of doctors and medical experts which finds that new treatments for hepatitis C are “cost effective.”...   Read More

New PhRMA and Epilepsy Foundation Report: 420 Medicines in Development for Neurological Disorders

By Tina Stow  |    July 13, 2015
It’s hard to imagine, but there are currently more than 50 million Americans – nearly one-sixth of our population – affected by some type of neurological disorder. While some of these are more...   Read More

Medicare Monday: New Video - How Patients Benefit from Medicare Part D

By Allyson Funk  |    July 13, 2015
Today is the 5th White House Conference on Aging and later this month Medicare will celebrate its 50th birthday. To celebrate, we’re releasing a new video on how patients benefit from Medicare Part D.   Read More

Week in Review: The Latest from PhRMA

By Priscilla VanderVeer  |    July 10, 2015
Healthy Outlook: The Cancer Support Community’s Rob Goldsmith highlighted a new report from his organization that found discrepancies in the definition of value in cancer care. July 15 Webcast Will...   Read More

CSC Survey Finds Discrepancy in Definition of Value in Cancer Care

By Guest Contributor  |    July 9, 2015
A recent survey of 769 metastatic breast cancer patients found there is a significant discrepancy in the definition of value within cancer care. Conducted by the Cancer Support Community (CSC),...   Read More

PhRMA Webcast to Examine Progress and Promise of Alzheimer’s Research

By Tina Stow  |    July 9, 2015
Alzheimer’s disease has a devastating impact on patients, their loved ones and the caregivers who help them navigate their daily lives. It’s a particularly cruel disease – one that is especially...   Read More

New Infographic: Medicines Cut Health Care Costs

By Holly Campbell  |    July 8, 2015
Retail prescription medicines account for just 10 percent of U.S. health care spending and are often the most cost-effective means of preventing and treating disease. A 2013 study by IMS Institute...   Read More

Biopharmaceutical Innovation Benefits Many Sectors of Industry

By PhRMA Staff  |    July 8, 2015
While the connection between sectors isn’t obvious to many, the sheet metal industry plays an integral role in the development of new medicines. Without it, many innovative new treatment options...   Read More

Medicare Monday: Celebrating Medicare

By Allyson Funk  |    July 6, 2015
Welcome back to Medicare Monday and happy July! This is a big month for Medicare so we hope you’ll check back with us regularly as we celebrate some big occasions. Next Monday, July 13th, is the ...   Read More

Outdated FDA Regulations Discourage Development and Dissemination of Healthcare Economic Data to Support Value-Based Healthcare

By Randy Burkholder  |    July 2, 2015
As demand for evidence about the clinical and economic benefits of new treatments continues to grow, Food and Drug Administration (FDA) regulations on communications by biopharmaceutical companies...   Read More

ICYMI: New Report on Benefits of Cancer Medicines That Emerge After FDA Approval

By Emma Van Hook  |    July 1, 2015
In case you missed it, Boston Healthcare Associates recently published a report examining how additional benefits of cancer medicines emerge over time through ongoing research after initial approval...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates